0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 61-80 of 196 Articles
Original Investigation |  FREE
Mark A. Espeland, PhD; Sally A. Shumaker, PhD; Iris Leng, PhD, MD; et al.
JAMA Intern Med. 2013;173(15):1429-1436. doi:10.1001/jamainternmed.2013.7727.

Comment and Response | 
L. John Hoffer, MD, PhD
JAMA Intern Med. 2013;173(14):1384. doi:10.1001/jamainternmed.2013.7731.

Comment and Response | 
Hans-Göran Tiselius, MD; Agneta Åkesson, PhD; Laura D. K. Thomas, MSc
JAMA Intern Med. 2013;173(14):1384a. doi:10.1001/jamainternmed.2013.7699.

Original Investigation |  FREE
Amit S. Chitnis, MD, MPH; Stacy M. Holzbauer, DVM, MPH; Ruth M. Belflower, RN, MPH; et al.
JAMA Intern Med. 2013;173(14):1359-1367. doi:10.1001/jamainternmed.2013.7056.
Includes: CME

Invited Commentary | 
Kent A. Sepkowitz, MD
JAMA Intern Med. 2013;173(14):1367-1368. doi:10.1001/jamainternmed.2013.7940.

Original Investigation |  FREE
Ishak Mansi, MD; Christopher R. Frei, PharmD, MSc; Mary Jo Pugh, PhD; et al.
JAMA Intern Med. 2013;173(14):1318-1326. doi:10.1001/jamainternmed.2013.6184.
Includes: Supplemental Content

Research Letter |  FREE
Lilian M. Abbo, MD; Susan E. Beekmann, RN, MPH; Thomas M. Hooton, MD; et al.
JAMA Intern Med. 2013;173(14):1376-1378. doi:10.1001/jamainternmed.2013.6480.
Includes: Supplemental Content

Invited Commentary | 
Kasia J. Lipska, MD, MHS; Victor M. Montori, MD
JAMA Intern Med. 2013;173(14):1306-1307. doi:10.1001/jamainternmed.2013.6189.

Invited Commentary | 
Prescott G. Woodruff, MD, MPH
JAMA Intern Med. 2013;173(13):1184-1185. doi:10.1001/jamainternmed.2013.1201.

Original Investigation |  FREE
Andrea Gershon, MD, MS; Ruth Croxford, MSc, PStat; Andrew Calzavara, MSc; et al.
JAMA Intern Med. 2013;173(13):1175-1185. doi:10.1001/jamainternmed.2013.1016.

Viewpoint | 
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Intern Med. 2013;173(13):1169-1170. doi:10.1001/jamainternmed.2013.854.

Research Letters |  FREE
Nina Rieckmann, PhD; Ian M. Kronish, MD, MPH; Peter A. Shapiro, MD; et al.
JAMA Intern Med. 2013;173(12):1150-1151. doi:10.1001/jamainternmed.2013.910.
Includes: Supplemental Content

Original Investigation |  FREE
Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; et al.
JAMA Intern Med. 2013;173(12):1075-1081. doi:10.1001/jamainternmed.2013.714.
Includes: Supplemental Content

Invited Commentary | 
Marko Mrkobrada, MD, FRCPC; Daniel G. Hackam, MD, PhD, FRCPC
JAMA Intern Med. 2013;173(12):1082-1083. doi:10.1001/jamainternmed.2013.718.

Special Article | 
Peter Doshi, PhD
JAMA Intern Med. 2013;173(11):1014-1016. doi:10.1001/jamainternmed.2013.490.
Includes: CME

Viewpoint | 
Iona Heath, MA, MB, BCh
JAMA Intern Med. 2013;173(11):956-957. doi:10.1001/jamainternmed.2013.970.

Editor's Correspondence | 
Shih-Wei Lai, MD; Kuan-Fu Liao, MD, MS
JAMA Intern Med. 2013;173(10):934-935. doi:10.1001/jamainternmed.2013.386.

Research Letters |  FREE
Gilles Safa, MD; Laure Darrieux, MD
JAMA Intern Med. 2013;173(10):924-926. doi:10.1001/jamainternmed.2013.374.

Research Letters |  FREE
Ziv Harel, MD, MSc; Shai Harel, MD, MS; Ron Wald, MDCM, MPH; et al.
JAMA Intern Med. 2013;173(10):929-930. doi:10.1001/jamainternmed.2013.379.
Includes: Supplemental Content

Invited Commentary | 
Eleni Linos, MD, DrPH
JAMA Intern Med. 2013;173(10):920-937. doi:10.1001/jamainternmed.2013.743.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Ophthalmology
Observation  | 
Unexpected Hypotony After Glaucoma Drainage Implant Surgery Associated With Anti–Vascular Endothelial Growth Factor Treatment
Ambika Hoguet, MD; Richard K. Parrish II, MD